Study of a New Drug Combination in Healthy Adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests how a new combination of drugs (BR3006A, BR3006B, and BR3006C) is absorbed and processed by the body when taken together, compared to a single tablet (BR3006). It is for healthy adults to understand the safety and behavior of the medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You need to be in good general health as confirmed by routine lab tests and an electrocardiogram (ECG).
- You must not have taken part in another clinical trial (including bioequivalence studies) in the last 6 months.
- You must not have had stomach or bowel surgery (other than appendix or hernia repair) or have a stomach/bowel disease that could affect how the study drug is absorbed.
- If you are a woman, you must not be pregnant, think you might be pregnant, or be breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the body processes different forms of a drug called BR3006 in healthy volunteers. It compares a single tablet (BR3006) to a combination of three separate components (BR3006A, BR3006B, and BR3006C) given together. This helps researchers understand if the combination works the same as the single tablet.
This trial tests the safety and how the body processes three common diabetes medications (dapagliflozin, linagliptin, and metformin) when taken together. Healthy volunteers are needed to help researchers understand how these drugs work in the body.
This study tests how the body handles three diabetes medicines (dapagliflozin, linagliptin, and metformin) when taken with food. It is for healthy volunteers to check safety and drug levels.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This trial tests a combination of three common diabetes medications (metformin, an SGLT2 inhibitor, and a TZD) to see how well they work together and if they are safe. It may help people with type 2 diabetes who need better blood sugar control.
This study is testing two different diabetes pills—dapagliflozin or pioglitazone—in people with type 2 diabetes. The goal is to see which one works better when added to your current metformin and DPP-4 inhibitor. You may qualify if your blood sugar is not well controlled with your current medications.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.